NCT06521788

Artificial Intelligence Assisted Breast Ultrasound in Breast Cancer Screening

Application Research of B-ultrasound Assisted by Artificial Intelligence in Breast Cancer Screening

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 21,790 (actual)
• Sponsor: Fudan University · Academic / Other
• Sex: Female
• Age: 35 Years – 70 Years
• Healthy volunteers: Accepted

Summary

AIBU is a randomized, open-label study assessing the effectiveness of an articificial intelligence-assisted breast ultrasound breast cancer screening strategy compared to standard screening (according to the current local guidelines in each participating area) in detecting late-stage breast cancers.

Detailed description

we enrolled asymptomatic women Women From January 2021 to December 2022, and then followed up for the next 1 year. The main study endpoint will be measured at the end of the one year after intervention.

Conditions

• Breast Cancer
• Screening

Interventions

Type	Name	Description
DEVICE	AI-assisted breast ultrasound	AI-assisted breast ultrasound in community-based breast cancer screening
DEVICE	Routine breast ultrasound	Routine breast ultrasound conducted by primary care physicians

Timeline

• Start date: 2020-09-01
• Primary completion: 2023-08-31
• Completion: 2023-12-31
• First posted: 2024-07-26
• Last updated: 2024-07-26

Locations

3 sites across 1 country: China